Sponsored By




Vote Therapeutic Bandage Products

for Venture

Therapeutic Bandage Products



Lawrence Silbart



Founder and Chief Scientific Officer



Therapeutic Bandage Products


City/Town where Organization Located

Farmington, CT


Company/organization description (<500 characters)

TBP is a research and development company making advanced bandage products using non-toxic, biodegradable microneedles to deliver biologics and therapeutic agents under the epidermis (stratum corneum) allowing wounds and infections to heal 'from the inside out'. Our product is targeted toward MRSA infections and chronic, non-healing wounds (e.g. diabetic foot ulcers, pressure ulcers, venous ulcers).


Tell us about the milestones your venture accomplished in 2019, eg., key team members added, revenue level achieved, major sales made or endorsements received, successful exit, etc... (<500 characters)

We have participated in Accelerate UConn, the NSF I-Corps CCEI Summer Fellowship program and have received seed funding from the BioScience Pipeline and Third Bridge Programs (both supported by CT-Next). We are currently enrolled in the ABCT program. We are in our third round of prototyping and have begun testing the product on explanted human skin. We have a six-member scientific team spanning the fields for microbiology, wound healing (clinical), pharmacology, skin pathology, biomedical engineering and immunology. We have also formed a four-member business advisory team.


Stage: Does your venture generate revenue? YES or NO

Not yet!


What CT entrepreneur ecosystem resources (spaces, programs, events, schools, etc.) have helped you succeed? (<500 characters)

As noted, we couldn't have made it this far without support from Accelerate UConn, the NSF I-Corps CCEI Summer Fellowship program, ABCT and funding from the BioScience Pipeline and Third Bridge Programs (both supported by CT-Next).


What people are saying about Therapeutic Bandage Products ...

 Therapeutic Bandage Products was created in response to a need for a better treatment for MRSA patients, and was inspired by an article UConn faculty, Dr. Lawrence Silbart read explaining the pains of patients and the frustration of wound care specialists in treating them. Current treatment includes high doses of antibiotics intravenously or orally, which is promoting antibiotic resistance which is a growing problem for the hospital community and beyond. Their device caters to advanced wound care by administering therapeutics through micro-needles to treat wounds including chronic non-healing wounds and Methicillin-resistant Staphylococcus aureus (MRSA). This venture has participated in CCEI’s Accelerate UConn and Summer Fellowship and has recently been invited to participate in the Accelerator for Biosciences in Connecticut (ABCT).  

Chereace Marcellin





Others in this category


Atelier Cho Thompson


Aureus Tech Inc


Bare Life


Byrd's Books


Conscious Capital Wealth Management


Convexity Scientific




DICOM Director




Engagement Solutions


Enviro Power


Everything Bags inc


FinTron Invest


Framework Television


Geyser Remediation


Goat Boy Soaps


Green Check Verified


Green Home Solutions


Healthy PlanEat


Higher Education Literacy Professionals








Lactation Innovations


Land Maverick


Levo International


Litchfield Distillery




Nami Therapeutics


New London Main Street


Noteworthy Chocolates


Oma's Pride


Paul's Custom Pet Food LLC


Phoenix Tailings




Rafael Goldstein and Tyler Lederer-Plaskett


Raise Green


ReNetX Bio


Ricker Duval


Roast Me


Rope Safe


SaniBrands, Inc.




Silver Fern Healthcare




Sound Affects








The Feel Good Lab


The Scoop Glastonbury


Traveling Chic Boutique




Villarina's Pasta Shop



Escort Girl